Dominik Menges graduated in Medicine from the University of Zurich in 2014.
After gaining clinical experience working as a resident doctor in Internal Medicine
for two years, he completed a MSc in Public Health at the London School of
Hygiene & Tropical Medicine. Dominik Menges joined the EBPI as a PhD candidate under the supervision of Prof. Dr. Milo Puhan in November 2018. His doctoral research is focused on methodological aspects and applications of benefit-harm assessment and patient preferences in patient-centered care, health technology assessment and public health decision-making. Dominik Menges further co-coordinates the Zurich SARS-CoV-2 Cohort study and conducts research on the longer-term health effects and immune responses after SARS-CoV-2 infection aiming to support public health decision-making.
- Google Scholar: https://scholar.google.ch/citations?user=z7uT4cUAAAAJ
- ORCID https://orcid.org/0000-0001-5970-1846
- Patient Preferences Regarding Benefits and Harms of Advanced Prostate Cancer Treatments in Switzerland
- Towards a long-term control of SARS-CoV-2 transmission – Identifying the epidemiological, immunological and viral genetic drivers of SARS-CoV-2 transmission and pathogenesis in a representative population-based cohort